| 51 |
11028250 | Comparative inhibitory activity of rofecoxib, meloxicam, diclofenac, ibuprofen, and naproxen on COX-2 versus COX-1 in healthy volunteers. | 2000 Oct |
1 |
| 52 |
11153163 | Renal damage induced by the treatment with non-opioid analgesics--theoretical assumption or clinical significance. | 2000 |
1 |
| 53 |
9874808 | Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: the human pharmacology of a selective inhibitor of COX-2. | 1999 Jan 5 |
1 |
| 54 |
10391671 | Cyclooxygenase-2 inhibition by rofecoxib reverses naturally occurring fever in humans. | 1999 Jun |
1 |
| 55 |
10500058 | A randomized trial comparing the effect of rofecoxib, a cyclooxygenase 2-specific inhibitor, with that of ibuprofen on the gastroduodenal mucosa of patients with osteoarthritis. Rofecoxib Osteoarthritis Endoscopy Study Group. | 1999 Oct |
1 |
| 56 |
9680006 | Regulation of macrophage eicosanoid generation is dependent on nuclear factor kappaB. | 1998 Jul |
1 |
| 57 |
9765255 | Platelet-derived growth factor-BB and thrombin generate positive and negative signals for human hepatic stellate cell proliferation. Role of a prostaglandin/cyclic AMP pathway and cross-talk with endothelin receptors. | 1998 Oct 16 |
1 |
| 58 |
9831331 | Cyclooxygenase selectivity and the risk of gastro-intestinal complications of various non-steroidal anti-inflammatory drugs: a clinical consideration. | 1998 Oct |
1 |